Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The glucagon receptor (GCGR) is a class B G-protein coupled receptor primarily activated by the peptide hormone glucagon. It plays a central role in maintaining blood glucose levels during fasting or hypoglycemia by stimulating hepatic glucose production and inhibiting insulin secretion. Dysregulation of GCGR contributes to hyperglucagonemia seen in diabetes mellitus. Recent structural studies have revealed detailed interactions between ECD/ECL/stalk/TMD regions critical for ligand recognition/activation.
Pharmacological antagonism of GCGR reduces blood glucose.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glucagon Receptor.